The Fragile X Messenger Ribonucleoprotein 1 regulates the morphology and maturation of human and rat oligodendrocytes

Vidya Ramesh,Ioanna Kougianou,Eleni Tsoukala,Zrinko Kozic,Karen Burr,Biju Viswanath,David Hampton,David Story,Bharath Kumar Reddy,Rakhi Pal,Owen Robert Dando,Peter C Kind,Sumantra Chattarji,Bhuvaneish Thangaraj Selvaraj,Siddharthan Chandran,Lida Zoupi

DOI: https://doi.org/10.1101/2024.08.16.608069

2024-08-19

Abstract:The Fragile X Messenger Ribonucleoprotein (FMRP) is an RNA binding protein that regulates the translation of multiple mRNAs and is expressed by neurons and glia in the mammalian brain. Loss of FMRP leads to Fragile X Syndrome (FXS), a common inherited form of intellectual disability and autism. While most research has been focusing on the neuronal contribution to FXS pathophysiology, the role of glia, particularly oligodendrocytes, is largely unknown. FXS individuals are characterised by white matter changes which imply impairments in oligodendrocyte differentiation and myelination. We hypothesized that FMRP regulates oligodendrocyte maturation and myelination during postnatal development. Using a combination of human pluripotent stem cell - derived oligodendrocytes and an Fmr1 knockout rat model, we studied the role of FMRP on mammalian oligodendrocyte development. We found that the loss of FMRP leads to shared defects in oligodendrocyte morphology in both rat and human systems in vitro which persist in the presence of FMRP expressing axons in chimeric engraftment models. Our findings point to species-conserved, cell-autonomous defects during oligodendrocyte maturation in FXS.

Neuroscience

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of Fragile X Messenger Ribonucleoprotein 1 (FMRP) in the development of human and rat oligodendrocytes, especially its impact on oligodendrocyte maturation and myelination. Specifically, the researchers hypothesized that FMRP regulates oligodendrocyte maturation and myelination during postnatal development, and verified this hypothesis by using human pluripotent stem cell - derived oligodendrocytes and Fmr1 - gene - knockout rat models. The study found that the absence of FMRP leads to morphological defects in oligodendrocytes, which exist in both rat and human systems in vitro experiments, and still exist in chimeric transplantation models, even in the presence of axons expressing FMRP. In addition, the study also found that these cell - autonomous defects significantly affect their myelination potential. These findings indicate that in Fragile X Syndrome (FXS), the absence of FMRP leads to specific dysfunctions of oligodendrocytes, which are reflected in both human and rat oligodendrocytes and have potential clinical translation significance.